Differential DNase I Hypersensitivity Reveals Factor-dependent Chromatin Dynamics
Overview
Affiliations
Transcription factor cistromes are highly cell-type specific. Chromatin accessibility, histone modifications, and nucleosome occupancy have all been found to play a role in defining these binding locations. Here, we show that hormone-induced DNase I hypersensitivity changes (ΔDHS) are highly predictive of androgen receptor (AR) and estrogen receptor 1 (ESR1) binding in prostate cancer and breast cancer cells, respectively. While chromatin structure prior to receptor binding and nucleosome occupancy after binding are strikingly different for ESR1 and AR, ΔDHS is highly predictive for both. AR binding is associated with changes in both local nucleosome occupancy and DNase I hypersensitivity. In contrast, while global ESR1 binding is unrelated to changes in nucleosome occupancy, DNase I hypersensitivity dynamics are also predictive of the ESR1 cistrome. These findings suggest that AR and ESR1 have distinct modes of interaction with chromatin and that DNase I hypersensitivity dynamics provides a general approach for predicting cell-type specific cistromes.
IGN: Invariable gene set-based normalization for chromatin accessibility profile data analysis.
Hu S, Xue H, Zang C Comput Struct Biotechnol J. 2025; 27:501-507.
PMID: 39931505 PMC: 11808601. DOI: 10.1016/j.csbj.2025.01.018.
Non-coding genetic variants underlying higher prostate cancer risk in men of African ancestry.
Hannenhalli S, Li S, Fatema K, Nidharshan S, Singh A, Rajagopal P Res Sq. 2024; .
PMID: 39678351 PMC: 11643368. DOI: 10.21203/rs.3.rs-5485172/v1.
Relaxin Modulates the Genomic Actions and Biological Effects of Estrogen in the Myometrium.
Tripathy S, Nagari A, Chiu S, Nandu T, Camacho C, Mahendroo M Endocrinology. 2024; 165(11).
PMID: 39283953 PMC: 11462454. DOI: 10.1210/endocr/bqae123.
Relaxin Modulates the Genomic Actions and Biological Effects of Estrogen in the Myometrium.
Tripathy S, Nagari A, Chiu S, Nandu T, Camacho C, Mahendroo M bioRxiv. 2024; .
PMID: 38659934 PMC: 11042280. DOI: 10.1101/2024.04.15.589654.
AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer.
Kiliti A, Sharif G, Martin M, Wellstein A, Riegel A Front Endocrinol (Lausanne). 2023; 14:1250218.
PMID: 37711895 PMC: 10498919. DOI: 10.3389/fendo.2023.1250218.